We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Reticulocalbin-2 promotes the proliferation and migration of oral squamous cell carcinoma by regulating the EGFRERK pathway.
- Authors
Wending Gao; Feng Cai; Xiaoli Jiang; Chengchao Fan
- Abstract
Purpose: To investigate the expression of reticulocalbin-2 (RCN2) in human oral squamous cell carcinoma (OSCC) tissues and cell lines and its effects on the proliferation and migration of OSCC cells. Methods: Immunohistochemical (IHC) assays were performed to evaluate the expression of RCN2 in 30 histologically-confirmed OSCC patient tissues and adjacent tissues. Immunoblot assays were performed to examine the expression of RCN2 in an oral mucosal keratinocyte cell line and OSCC cell lines, while the effects of RCN2 on OSCC cell proliferation were assessed by CCK-8 and colony formation assays. The effects of RCN2 on OSCC cell motility were determined using wound closure and Transwell assays. Furthermore, the effect of RCN2 on EGFR/ERK pathway in OSCC cells was evaluated by immunoblot assay. Results: Overexpression of RCN2 occurred in OSCC tissues and cells (p < 0.01). RCN2 also increased the proliferation of OSCC cells and stimulated the motility of OSCC cells in vitro (p < 0.01). These effects occurred as a result of the regulation of EGFR/ERK signaling pathway by RCN2. Conclusion: RCN2 is a potential therapeutic target for OSCC treatment. However, further in vivo studies are required to validate these findings.
- Subjects
SQUAMOUS cell carcinoma; CELL migration; CELL motility; CELL lines; CELL proliferation
- Publication
Tropical Journal of Pharmaceutical Research, 2022, Vol 21, Issue 12, p2525
- ISSN
1596-5996
- Publication type
Article
- DOI
10.4314/tjpr.v21i12.4